{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:20:17Z","timestamp":1761110417102},"reference-count":39,"publisher":"Instituto Nacional de Salud Publica","issue":"6, nov-dic","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Salud Publica Mex"],"DOI":"10.21149\/8461","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:50:59Z","timestamp":1544748659000},"page":"633","source":"Crossref","is-referenced-by-count":5,"title":["Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study"],"prefix":"10.21149","volume":"60","author":[{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staci L","family":"Sudenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B Nelson","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leith","family":"Le\u00f3n-Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betania","family":"Allen-Leigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Posso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Quiterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Pilar","family":"Hern\u00e1ndez-Nevares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8786","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Kjaer SK,Tran TN, Sparen P,Tryggvadottir L, Munk C, Dasbach E, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis. 2007;196(10):1447-54. https:\/\/doi.org\/10.1086\/522863","DOI":"10.1086\/522863"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Dinh TH, Sternberg M, Dunne EF, Markowitz LE. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004. Sex Transm Dis. 2008;35(4):357-60. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181632d61","DOI":"10.1097\/OLQ.0b013e3181632d61"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis. 2010;10:360. https:\/\/doi.org\/10.1186\/1471-2334-10-360","DOI":"10.1186\/1471-2334-10-360"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Dominiak-Felden G, Gobbo C, Simondon F. Evaluating the early benefit of quadrivalent HPV vaccine on genital warts in Belgium:A cohort study. PLoS One. 2015;10(7):e0132404. https:\/\/doi.org\/10.1371\/journal.pone.0132404","DOI":"10.1371\/journal.pone.0132404"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study. Sex Transm Dis. 2013;40(1):28-31. https:\/\/doi.org\/10.1097\/OLQ.0b013e3182756efd","DOI":"10.1097\/OLQ.0b013e3182756efd"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Park IU, Introcaso C, Dunne EF. Human Papillomavirus and genital warts: A review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(suppl 8):S849-55. https:\/\/doi.org\/10.1093\/cid\/civ813","DOI":"10.1093\/cid\/civ813"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805-14. https:\/\/doi.org\/10.1086\/597071","DOI":"10.1086\/597071"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Stensen S, Kjaer SK, Jensen SM, Frederiksen K, Junge J, Iftner T, et al. Factors associated with type-specific persistence of high-risk human papillomavirus infection:A population-based study. Int J Cancer.2016;138(2):361-8. https:\/\/doi.org\/10.1002\/ijc.29719","DOI":"10.1002\/ijc.29719"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Bollerup S, Baldur-Felskov B, Blomberg M, Baandrup L, Dehlendorff C, Kjaer SK. Significant reduction in the incidence of genital warts in young men 5 years into the Danish Human PapillomavirusVaccination Program for girls and women. Sex Transm Dis. 2016;43(4):238-42. https:\/\/doi.org\/10.1097\/OLQ.0000000000000418","DOI":"10.1097\/OLQ.0000000000000418"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, et al. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2015;91(3):214-9. https:\/\/doi.org\/10.1136\/sextrans-2014-051813","DOI":"10.1136\/sextrans-2014-051813"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Sudenga SL, Ingles DJ, Pierce-Campbell CM, Lin HY, FulpWJ, Messina JL, et al. Genital Human Papillomavirus infection progression to external genital lesions:The HIM Study. Eur Urol. 2016;69(1):166-73. https:\/\/doi.org\/10.1016\/j.eururo.2015.05.032","DOI":"10.1016\/j.eururo.2015.05.032"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Giuliano AR, Lazcano E,Villa LL, Flores R, Salmeron J, Lee JH, et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer. 2009;124(6):1251-7. https:\/\/doi.org\/10.1002\/ijc.24097","DOI":"10.1002\/ijc.24097"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Giuliano AR, Lee JH, FulpW,Villa LL, Lazcano E, Papenfuss MR, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet. 2011;377(9769):932-40. https:\/\/doi.org\/10.1016\/S0140-6736(10)62342-2","DOI":"10.1016\/S0140-6736(10)62342-2"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JCM.36.10.3020-3027.1998","article-title":"Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.","volume":"36","author":"Gravitt","year":"1998","unstructured":"14. Gravitt PE, Peyton CL,Apple RJ,Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36(10):3020-7.","journal-title":"J Clin Microbiol","ISSN":"http:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. CoglianoV, Baan R, Straif K, GrosseY, Secretan B, El Ghissassi F,WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6(4):204. https:\/\/doi.org\/10.1016\/S1470-2045(05)70086-3","DOI":"10.1016\/S1470-2045(05)70086-3"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Anic GM, Messina JL, Stoler MH, Rollison DE, Stockwell H, Villa LL, et al. Concordance of human papillomavirus types detected on the surface and in the tissue of genital lesions in men. J MedVirol. 2013;85(9):1561-6. https:\/\/doi.org\/10.1002\/jmv.23635","DOI":"10.1002\/jmv.23635"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Coutl\u00e9e F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol. 2006;44(6):1998-2006. https:\/\/doi.org\/10.1128\/JCM.00104-06","DOI":"10.1128\/JCM.00104-06"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.Ying Z,Wei L.The Kaplan-Meier estimate for dependent failure time observations. J Multivar Anal. 1994;50(1):17-29. https:\/\/doi.org\/10.1006\/jmva.1994.1031","DOI":"10.1006\/jmva.1994.1031"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Woodhall SC, Jit M, Soldan K, Kinghorn G, Gilson R, Nathan M, et al. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sex Transm Infect. 2011;87(6):458-63. https:\/\/doi.org\/10.1136\/sextrans-2011-050073","DOI":"10.1136\/sextrans-2011-050073"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Tan LS, Chio MT, Sen P, Lim YK, Ng J, Ilancheran A, et al. Assessment of psychosocial impact of genital warts among patients in Singapore. Sex Health. 2014;11(4):313-8. https:\/\/doi.org\/10.1071\/SH13189","DOI":"10.1071\/SH13189"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. \u00d6stensson E, Fr\u00f6berg M, Leval A, Hellstr\u00f6m AC, B\u00e4cklund M, Zethraeus N, et al. Cost of preventing, managing, and treating Human Papillomavirus (HPV)-related diseases in Sweden before the introduction of quadrivalent HPV vaccination. PLoS One. 2015;10(9):e0139062. https:\/\/doi.org\/10.1371\/journal.pone.0139062","DOI":"10.1371\/journal.pone.0139062"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/sti.71.6.387","article-title":"Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution","volume":"71","author":"Strand","year":"1995","unstructured":"22. Strand A, Brinkeborn R, Siboulet A.Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourinary medicine. 1995;71:387-90.","journal-title":"Genitourinary medicine"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Lacey CJ,Woodhall SC,Wikstrom A, Ross J. 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2013;27(3):e263-70. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04493.x","DOI":"10.1111\/j.1468-3083.2012.04493.x"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Pichon-Riviere A, Alcaraz A, Caporale J, Bardach A, Rey-Ares L, Klein K, et al. Cost-effectiveness of quadrivalent vaccine against human papilloma virus in Argentina based on a dynamic transmission model. Salud Publica Mex. 2015;57(6):504-13. https:\/\/doi.org\/10.21149\/spm.v57i6.7639","DOI":"10.21149\/spm.v57i6.7639"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Lazcano-Ponce E, P\u00e9rez G, Cruz-Valdez A, Zamilpa L,Aranda-Flores C, Hern\u00e1ndez-Nevarez P, et al. Impact of a quadrivalent HPV6\/11\/16\/18 vaccine in Mexican women: public health implications for the region. Arch Med Res. 2009;40(6):514-24. https:\/\/doi.org\/10.1016\/j.arcmed.2009.07.008","DOI":"10.1016\/j.arcmed.2009.07.008"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Donne AJ, Hampson L, Homer JJ, Hampson IN.The role of HPV type in Recurrent Respiratory Papillomatosis. Int J Pediatr Otorhinolaryngol. 2010;74(1):7-14. https:\/\/doi.org\/10.1016\/j.ijporl.2009.09.004","DOI":"10.1016\/j.ijporl.2009.09.004"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Granados-Garc\u00eda M. Oropharyngeal cancer: an emergent disease? Salud Publica Mex. 2016;58:285-90. https:\/\/doi.org\/10.21149\/spm.v58i2.7798","DOI":"10.21149\/spm.v58i2.7798"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. ColesVA, Chapman R, Lanitis T, Carroll SM.The costs of managing genital warts in the UK by devolved nation: England, Scotland,Wales and Northern Ireland. Int J STD AIDS. 2016;27(1):51-7. https:\/\/doi.org\/10.1177\/0956462415573121","DOI":"10.1177\/0956462415573121"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. King EM, Gilson R, Beddows S, Soldan K, Panwar K, Young C, et al. Human papillomavirus DNA in men who have sex with men: type-specific prevalence,risk factors and implications for vaccination strategies. Br J Cancer. 2015;112(9):1585-93. https:\/\/doi.org\/10.1038\/bjc.2015.90","DOI":"10.1038\/bjc.2015.90"},{"issue":"2","key":"ref29","first-page":"99","article-title":"Prevalence of condyloma acuminata in women who went to opportune detection of cervicouterine cancer.","volume":"78","author":"Jim\u00e9nez-Vieyra","year":"2010","unstructured":"30. Jim\u00e9nez-Vieyra CR. Prevalence of condyloma acuminata in women who went to opportune detection of cervicouterine cancer. Ginecol Obstet Mex. 2010;78(2):99-102.","journal-title":"Ginecol Obstet Mex"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst.2013;105:175-201. https:\/\/doi.org\/10.1093\/jnci\/djs491","DOI":"10.1093\/jnci\/djs491"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Chatuvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, XiaoW, Kim E, etal. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-301. https:\/\/doi.org\/10.1200\/JCO.2011.36.4596","DOI":"10.1200\/JCO.2011.36.4596"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Frenk J, G\u00f3mez-Dant\u00e9s O. Healthcare or sickcare:reestablishing the balance. Salud Publica Mex. 2016;58:84-8. https:\/\/doi.org\/10.21149\/spm.v58i1.7671","DOI":"10.21149\/spm.v58i1.7671"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Salmer\u00f3n J,Torres-Ibarra L, Bosch FX, Cuzick J, L\u00f6rincz A,Wheeler CM, et al. HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico. Salud Publica Mex. 2016;58:211-9. https:\/\/doi.org\/10.21149\/spm.v58i2.7790","DOI":"10.21149\/spm.v58i2.7790"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Schmeler KM, Sturgis EM. Expanding the benefits of HPV vaccination to boys and men. Lancet. 2016;387(10030):1798-9. https:\/\/doi.org\/10.1016\/S0140-6736(16)30314-2","DOI":"10.1016\/S0140-6736(16)30314-2"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.Winer RL, Hughes JP, Feng Q, Stern JE, Xi LF, Koutsky LA. Incident detection of high-risk Human Papillomavirus infections in a cohort of highrisk women aged 25-65 years. J Infect Dis. 2016;214(5):665-75. https:\/\/doi.org\/10.1093\/infdis\/jiw074","DOI":"10.1093\/infdis\/jiw074"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Nyitray AG, Carvalho da Silva RJ, Chang M, Baggio ML, Ingles DJ, Abrahamsen M, et al. Incidence, duration, persistence, and factors associated with high-risk anal HPV persistence among HIV-negative men having sex with men:A multi-national study. Clin Infect Dis. 2016;62(11):1367-74. https:\/\/doi.org\/10.1093\/cid\/ciw140","DOI":"10.1093\/cid\/ciw140"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Garland SM, SubasingheAK, JayasingheYL,Wark JD, MoscickiAB, Singer A, et al. HPV vaccination for victims of childhood sexual abuse. Lancet. 2015;386(10007):1919-20. https:\/\/doi.org\/10.1016\/S0140-6736(15)00757-6","DOI":"10.1016\/S0140-6736(15)00757-6"},{"issue":"3","key":"ref38","first-page":"245","article-title":"A Contemporary Review of HPV and Penile Cancer.","volume":"30","author":"Stratton","year":"2016","unstructured":"39. Stratton KL, Culkin DJ.A Contemporary Review of HPV and Penile Cancer. Oncology (Williston Park). 2016;30(3):245-9.","journal-title":"Oncology (Williston Park)","ISSN":"http:\/\/id.crossref.org\/issn\/0890-9091","issn-type":"print"}],"container-title":["Salud P\u00fablica de M\u00e9xico"],"original-title":[],"link":[{"URL":"http:\/\/www.saludpublica.mx\/index.php\/spm\/article\/viewFile\/8461\/11679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.saludpublica.mx\/index.php\/spm\/article\/viewFile\/8461\/11679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T15:46:43Z","timestamp":1605628003000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.saludpublica.mx\/index.php\/spm\/article\/view\/8461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":39,"journal-issue":{"issue":"6, nov-dic","published-online":{"date-parts":[[2018,12,13]]}},"URL":"https:\/\/doi.org\/10.21149\/8461","relation":{},"ISSN":["1606-7916","0036-3634"],"issn-type":[{"value":"1606-7916","type":"electronic"},{"value":"0036-3634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,13]]}}}